Welcome to the PharmCast Research Store. Gain access to market leading research in your industry. You can browse through the portfolio of reports below or enter keywords in the search box to find the information you have been looking for.
  • Browse Reports & Briefs
  • Browse Company Profiles
  • Browse Industry Profiles
  • Latest News
Number of Employees

< 250 (30)

250 - 999 (22)

1,000 - 2,499 (20)

2,500 - 4,999 (29)

5,000 - 9,999 (56)

10,000 - 49,999 (113)

50,000+ (40)

Annual Revenue US$m

< 50 (19)

50 - 99 (7)

100 - 199 (8)

200 - 499 (20)

500 - 999 (11)

1,000 - 1,999 (45)

2,000+ (189)

Top stories

Thermo Fisher Scientific's NGS technology to support NCI-MATCH program

Thermo Fisher Scientific Inc. has announced that it will provide its next-generation sequencing, or NGS, technology to support the National Cancer Institute- Molecular Analysis for Therapy Choice, or NCI-MATCH, program...more >>

Epizyme announces positive data from Phase I B-cell NHL and solid tumor trial

Epizyme, Inc., a clinical stage biopharmaceutical company, has announced positive data from the ongoing Phase I trial of tazemetostat, a first-in-class EZH2 inhibitor, when used as an oral monotherapy in patients with advanced B-cell non-Hodgkin lymphomas, or NHL, and solid tumors...more >>

XenoPort and NIAAA announce initiation of alcohol use disorder trial

XenoPort, Inc., a biopharmaceutical company, and the National Institute on Alcohol Abuse and Alcoholism, or NIAAA, have announced that the NIAAA has initiated a clinical trial with XenoPort's HORIZANT, or gabapentin enacarbil, extended-release tablets as a new treatment for alcohol use disorder, or AUD...more >>

IMS and Foundation Medicine partner to advance precision medicines for cancer

IMS Health Holdings, Inc., a provider of healthcare information services, and Foundation Medicine, Inc., a provider of genomic analysis diagnostics, have collaborated to advance the understanding and effectiveness of precision medicines for treating cancer...more >>